InnovaHealth Partners

InnovaHealth Partners, LP advises two private pooled investment vehicles (InnovaHealth Partners Fund, LP and InnovaHealth Partners Fund II) and related co-investment vehicles for sophisticated, accredited and qualified investors, with subscriptions governed by each Fund’s offering documents. The Adviser provides discretionary portfolio management focused principally on equity investments in early- to mid-stage, post‑commercialization medical device companies seeking long‑term capital appreciation.

The firm pursues growth buyouts and platform-plus bolt-on strategies, emphasizing proactive sourcing rather than typical private equity auction processes, and targets opportunities across the United States, Europe and Israel. Its research program is built around conference attendance, clinical relationships, industry tracking and digital publication, and the Adviser conducts ongoing monitoring of portfolio companies while providing periodic and audited financial reporting to investors.

Distinctive disclosures in the Brochure include that the Adviser markets predecessor performance and that it has an affiliation with a commodity trading entity, both features that are uncommon among peers. The Brochure also notes governance and conflict‑mitigation practices that may affect investors, including a written Code of Ethics, pre‑clearance requirements for employee participation in private placements, potential side letters that can alter economic or other terms for certain investors, and the use of carried interest paid to an affiliate.